Abstract: | Highlights 1. Seven monoclonal antibodies (mAbs) against SARS-CoV-2 nucleocapsid protein are produced, which can be applied in ELISA, Western blotting, and immunofluorescence staining. 2. A pair of mAbs, 2G11/bio-1C7, can detect SARS-CoV-2 nucleocapsid protein as low as 15 pg/well in the double sandwich ELISA. 3. The mAb, 2G11, shows 97.4% sensitivity and 100% specificity for diagnosing the human blood samples. |